
Sign up to save your podcasts
Or


In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas, to talk about the role of secondary cytoreductive surgery in recurrent ovarian cancer. They discuss the importance, findings, and implications of surgical clinical trials such as GOG 213 and future studies on recurrent ovarian cancer.
By BMJ Group5
2323 ratings
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas, to talk about the role of secondary cytoreductive surgery in recurrent ovarian cancer. They discuss the importance, findings, and implications of surgical clinical trials such as GOG 213 and future studies on recurrent ovarian cancer.

37 Listeners

52 Listeners

5 Listeners

8 Listeners

5 Listeners

3 Listeners

2 Listeners

3 Listeners

8 Listeners

38 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

14 Listeners

3 Listeners

3 Listeners

23 Listeners